In recent years MBS has significantly increased its R&D facilities and assembled a dedicated team of R&D scientists whose only focus is to expand the antibody product line and add innovation to our custom services.
Click Here to See What’s New from MBS R&D
Collaboration Opportunities:
- Leverage 20+ years of premier Hybridoma Development Experience at MBS with your expertise in the target of shared market interest
- Generate a fair and mutually beneficial licensing agreement of the monoclonal antibody
- Gain access to (or leverage) MBS network of contacts in biotechnology and diagnostic industries to sell antibody and generate revenue for your institution
- Areas of collaborative interest
- Infectious Disease
- Veterinary Targets
- Biomarkers
- Food / Water Safety
- Drug Development
- Other
Contact Technical Marketing Analyst or Fill out our Application for Collaboration.